Physician

Monica E Bravo, MD

According to 2025 Medicare claims, Monica Bravo, MD (NPI: 1699303636) practices dermatology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1366936759; TIN: 391351587) and primary practice location at 36526-8706.

Bravo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 193 traditional Medicare patients, billed 1,008 HCPCS/CPT codes, and received $93,526 in Medicare payments. The top billing code was 12032 (Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm). Part D data shows 217 prescription claims across 92 beneficiaries totaling $181,307 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 37 records totaling $823. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$47K$94K2024 Medicare payment: $93,526 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20241931,008$93,526

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$91K$181K2021 Drug cost: $31,849 (USD; Tot_Drug_Cst)2022 Drug cost: $103,197 (USD; Tot_Drug_Cst)2023 Drug cost: $90,682 (USD; Tot_Drug_Cst)2024 Drug cost: $181,307 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20212157$31,849
202257163$103,197
202345121$90,682
202492217$181,307

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
12032Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm4950$212
11602Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm3637$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3646$63
17000Destruction of precancer skin growth, 1 growth4245$36
17003Destruction of precancer skin growth, 2-14 growths31130$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab13322$49,761
Clobetasol PropionateClobetasol Propionate31894$2,250
KetoconazoleKetoconazole391,057$444
Triamcinolone AcetonideTriamcinolone Acetonide17478$151
Doxycycline HyclateDoxycycline Hyclate12209$116

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.37$823ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Monica E. Bravo, MD?

Tedicare shows public-source Medicare data for Monica E. Bravo, MD (NPI 1699303636), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Monica E. Bravo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Monica E. Bravo, MD?

Monica E. Bravo, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1366936759) in the available physician profile data.

Does Monica E. Bravo, MD have Open Payments data?

Monica E. Bravo, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.